# Aptamer Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aptamer-sciences

- Industry: Biotechnology
- Headquarters: Pohang, South Korea
- Website: www.aptsci.com
- Total disclosed funding: $13M
- Latest round: Series B (Jul 12, 2018)
- Investors on record: 9

## About

Founded in 2011 and based in South Korea, Aptamer Sciences Inc. is a biotechnology company focused on commercializing technologies for the analysis of proteins. In 2016, Aptamer Sciences Inc. raised USD 4 million in venture funding from new investor Brightstar Partners.

The company applies aptamer-based technology to develop new drugs for various diseases. The company's product pipeline includes ApDC for solid rock and brain tumor, Chimeric Aptamer for Parkinson's disease and immune cancer, and aptamer for diabetes and covid-19. The company also provides services including aptamer synthesis services and aptamer excavation services.

## Funding rounds

- Series B, Jul 12, 2018, $8.6M — Korea Investment Partners, G.N.TECH Venture Capital, NHN Investment, Posco Investment, ID Ventures, SM-Sino Technology Investment, BSK Investment
- Series A, May 10, 2016, $4.1M — G.N.TECH Venture Capital, Kiwoom Investment, Brightstar Partners

## Investors

- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series A, Series B
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Series A
- Brightstar Partners (https://capitalatlas.ai/funds/brightstar-partners) — Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series B
- NHN Investment (https://capitalatlas.ai/funds/nhn-investment) — Series B
- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Series B
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Series B
- SM-Sino Technology Investment (https://capitalatlas.ai/funds/sm-sino-technology-investment) — Series B
- BSK Investment (https://capitalatlas.ai/funds/bsk-investment) — Series B